日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING.

BAG2 通过稳定 STING 来调节 I 型干扰素信号传导,从而抑制宫颈癌的进展

Yao Shijie, Chen Siming, Wang Anjin, Liang Ziyan, Liu Xuelian, Gao Yang, Cai Hongbing

PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription.

PPP1R13L 通过抑制 p63 介导的 PTEN 转录来驱动宫颈癌的进展

Wang Anjin, Liu Xuelian, Liang Ziyan, Yao Shijie, Wan Shimeng, Ren Hang, Gao Yang, Wang Hua, Cai Hongbin

LAG3 as a Tumor Suppressor and Immune Regulator in Cervical Cancer: From Functional Validation to Therapeutic Strategy

LAG3作为宫颈癌中的肿瘤抑制因子和免疫调节因子:从功能验证到治疗策略

Yao, Shijie; Chen, Siming; Wan, Shimeng; Wang, Anjin; Liang, Ziyan; Liu, Xuelian; Gao, Yang; Cai, Hongbing

Natural killer cell-related anti-tumour adoptive cell immunotherapy

自然杀伤细胞相关抗肿瘤过继细胞免疫疗法

Qi, Yuwen; Li, Ying; Wang, Hua; Wang, Anjin; Liu, Xuelian; Liang, Ziyan; Gao, Yang; Wei, Liqing

PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities

PROTACs在表观遗传癌症治疗中的应用:现状与未来机遇

Liu, Xuelian; Wang, Anjin; Shi, Yuying; Dai, Mengyuan; Liu, Miao; Cai, Hong-Bing